APP Plus Measure Deep Dive: Depression Screening & Follow-Up
If your practice participates in APP Plus, you already know how tight scoring margins can be. The Depression Screening and Follow-Up (CMS2v13) measure is one of those deceptively simple metrics that can quietly shift your overall APP Plus performance. Screening alone isn’t enough. What truly drives your score is how you document and act after a positive result.
At Chirpy Bird, we call CMS2v13 a “hidden performance booster.” It’s consistent, controllable, and fully within your operational power. The secret is to operationalize the follow-up portion, not just the screening. Here’s how to make this measure work harder for your practice and earn every available point.
The Measure in Context
CMS2v13 tracks whether patients aged 12 and older were screened for depression using a standardized tool, and whether those with positive results received a documented follow-up plan within two calendar days.
Why it matters: Depression affects adherence to treatment, chronic disease management, and the cost of care. Addressing it early improves quality and supports your APP Plus performance.
Measure Logic (Just the facts, no jargon)
Eligible Patients:
Age 12+
At least one eligible encounter in the performance year
Excluded Patients:
Prior diagnosis of depression or bipolar disorder
Medical conditions that prevent screening
Success Criteria:
Screening documented in structured EHR fields
Positive screens followed by a plan within 2 days
Workflow Optimization Steps
Step 1. Automate identification
Use EHR logic to flag all patients aged 12+ without a recent depression screening.
Step 2. Conduct and record screening
Administer the PHQ-2 or PHQ-9 during intake. Record the tool name and result in structured EHR fields.
Step 3. Document follow-up within 48 hours
If positive, record a follow-up plan the same day or the next. Include referrals, medication starts, or therapy scheduling.
Step 4. Validate monthly
Check for missing screenings, late follow-ups, and incorrect exclusions.
Common Errors and How to Outsmart Them
Strategic Advantage for APP Plus Participants
Align behavioral health partnerships.
Build a same-day referral system for positive screens.
Integrate CMS2v13 into multi-measure tracking.
Link it with CMS122v13 (Diabetes) or CMS130v12 (Colorectal Cancer Screening) in your APP Plus dashboard.
Leverage data for payer relations
Show improvement trends in depression screening and follow-up. It signals care coordination success and supports your value-based contracts.
30-Day Action Plan
Confirm PHQ tools are embedded in structured fields.
Verify automatic 48-hour follow-up prompts for positives.
Build an APP Plus “eligible now” visual dashboard.
Schedule monthly validation runs.
Create a “positive screen quick plan” template.
Conduct a 10-chart mini-audit to catch gaps.
So there you have it …,
CMS2v13 rewards practices that are disciplined, not just diligent. When your workflows are standardized and follow-up plans are consistently documented, your depression screening data strengthens both quality reporting and patient care.
If your ACO or group practice is ready to tighten up its CMS2v13 strategy, Chirpy Bird can help you streamline your process, validate data, and maximize APP Plus performance.
Visit chirpybirdinc.com to get started.
Let’s turn compliance into confidence, one measure at a time.
“Smarter Compliance. Better Care.”
